Article
Striving toward hyperthermia-free analgesia: lessons from loss-of-function mutations of human TRPV1.
The Journal of clinical investigation - 1 Feb 2023
Li Tingting, Chung Man-Kyo
Abstract excerpt
Transient receptor potential vanilloid 1 (TRPV1), a receptor for capsaicin and noxious heat, has been one of the most compelling targets for analgesics. However, systemic inhibition of TRPV1 is an impractical approach as a pain killer, since systemic antagonism induces hyperthermia. Two articles in this issue of the JCI report phenotypes from separate, rare missense mutations of human TRPV1. He, Zambelli, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
